Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	CM Relapsed/Refractory	1	11
Total, all-cause mortality	ACM Relapsed/Refractory	11	79
Total, all-cause mortality	ACM Newly Diagnosed	1	14
Total, all-cause mortality	ACM Total	12	93
Total, other adverse events	CM Relapsed/Refractory	11	11
Total, other adverse events	ACM Relapsed/Refractory	79	79
Total, other adverse events	ACM Newly Diagnosed	14	14
Total, other adverse events	ACM Total	93	93
Total, serious adverse events	CM Relapsed/Refractory	3	11
Total, serious adverse events	ACM Relapsed/Refractory	31	79
Total, serious adverse events	ACM Newly Diagnosed	4	14
Total, serious adverse events	ACM Total	35	93

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02520011/event-totals